Hangzhou Minsheng Healthcare Co., Ltd. (SHE:301507)
China · Delayed Price · Currency is CNY 12.83
-0.07 (-0.54%)
At close: May 28, 2026
SHE:301507 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 824.69 | 778.67 | 638.76 | 580.36 | 545.65 | 487.91 |
Other Revenue | 2.96 | 2.96 | 2.49 | 1.37 | 1.47 | 1.66 |
| 827.65 | 781.63 | 641.25 | 581.73 | 547.12 | 489.58 | |
Revenue Growth (YoY) | 22.05% | 21.89% | 10.23% | 6.33% | 11.75% | 11.41% |
Cost of Revenue | 398.88 | 384.1 | 288.19 | 225.42 | 219.47 | 169.18 |
Gross Profit | 428.77 | 397.53 | 353.06 | 356.32 | 327.65 | 320.4 |
Selling, General & Admin | 300.87 | 280.54 | 246.23 | 240.88 | 219.63 | 226.67 |
Research & Development | 26.15 | 26.08 | 23.98 | 29.56 | 27.17 | 24.07 |
Other Operating Expenses | 6.95 | 5.04 | 7.07 | 5.95 | 5.64 | 7.39 |
Operating Expenses | 334.42 | 310.4 | 277.96 | 277.3 | 252.25 | 258.51 |
Operating Income | 94.35 | 87.14 | 75.1 | 79.02 | 75.4 | 61.89 |
Interest Expense | -0.04 | -0.06 | -0.06 | -0.11 | -0.16 | -0.51 |
Interest & Investment Income | 21.07 | 22.1 | 29.5 | 13.98 | 8.79 | 10.48 |
Currency Exchange Gain (Loss) | 0.01 | 0.01 | -0.06 | - | - | - |
Other Non Operating Income (Expenses) | -0.15 | -0.07 | -0.82 | -0.12 | -0.08 | 6.97 |
EBT Excluding Unusual Items | 115.24 | 109.12 | 103.66 | 92.77 | 83.95 | 78.84 |
Gain (Loss) on Sale of Investments | 18.14 | 23.88 | -0.5 | 1.06 | -0.46 | -2.65 |
Gain (Loss) on Sale of Assets | -0.21 | -0 | - | - | -0 | 0.18 |
Asset Writedown | 1.75 | -0.08 | -0 | - | -0.27 | -0.29 |
Other Unusual Items | 5.14 | 4.56 | 3.1 | 2.98 | 4.85 | 2.86 |
Pretax Income | 140.06 | 137.48 | 106.25 | 96.8 | 88.07 | 78.94 |
Income Tax Expense | 18.75 | 16.44 | 14.42 | 11.16 | 9.06 | 8.71 |
Earnings From Continuing Operations | 121.3 | 121.05 | 91.83 | 85.63 | 79.01 | 70.22 |
Minority Interest in Earnings | -2.44 | -2.26 | - | - | - | - |
Net Income | 118.86 | 118.79 | 91.83 | 85.63 | 79.01 | 70.22 |
Net Income to Common | 118.86 | 118.79 | 91.83 | 85.63 | 79.01 | 70.22 |
Net Income Growth | 24.25% | 29.35% | 7.24% | 8.38% | 12.51% | 38.46% |
Shares Outstanding (Basic) | 360 | 360 | 353 | 295 | 263 | 260 |
Shares Outstanding (Diluted) | 360 | 360 | 353 | 295 | 263 | 260 |
Shares Change (YoY) | 1.91% | 1.92% | 19.61% | 12.12% | 1.26% | 9.28% |
EPS (Basic) | 0.33 | 0.33 | 0.26 | 0.29 | 0.30 | 0.27 |
EPS (Diluted) | 0.33 | 0.33 | 0.26 | 0.29 | 0.30 | 0.27 |
EPS Growth | 21.92% | 26.92% | -10.35% | -3.33% | 11.11% | 26.70% |
Free Cash Flow | -0.37 | -19.16 | 13.57 | 72.08 | 68.37 | 18.75 |
Free Cash Flow Per Share | -0.00 | -0.05 | 0.04 | 0.24 | 0.26 | 0.07 |
Dividend Per Share | 0.150 | 0.150 | 0.100 | 0.100 | - | - |
Dividend Growth | 50.00% | 50.00% | - | - | - | - |
Gross Margin | 51.81% | 50.86% | 55.06% | 61.25% | 59.89% | 65.44% |
Operating Margin | 11.40% | 11.15% | 11.71% | 13.58% | 13.78% | 12.64% |
Profit Margin | 14.36% | 15.20% | 14.32% | 14.72% | 14.44% | 14.34% |
Free Cash Flow Margin | -0.04% | -2.45% | 2.12% | 12.39% | 12.50% | 3.83% |
EBITDA | 122.47 | 114.11 | 97.47 | 105.66 | 106.79 | 91.42 |
EBITDA Margin | 14.80% | 14.60% | 15.20% | 18.16% | 19.52% | 18.67% |
D&A For EBITDA | 28.12 | 26.97 | 22.37 | 26.64 | 31.39 | 29.53 |
EBIT | 94.35 | 87.14 | 75.1 | 79.02 | 75.4 | 61.89 |
EBIT Margin | 11.40% | 11.15% | 11.71% | 13.58% | 13.78% | 12.64% |
Effective Tax Rate | 13.39% | 11.96% | 13.57% | 11.53% | 10.29% | 11.04% |
Revenue as Reported | 827.65 | 781.63 | 641.25 | 581.73 | 547.12 | - |
Advertising Expenses | - | 41.74 | 37.41 | 34.43 | 77.05 | 91.52 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.